Text Size

Study the Role of Genetic Variation in the Determining Lipid Profile Response to Dietary Change

This study has been completed.
Sponsor:
Information provided by:
Tabriz University
ClinicalTrials.gov Identifier:
NCT00673023
First received: May 4, 2008
Last updated: NA
Last verified: May 2008
History: No changes posted
  Purpose

The purpose of this study is to determine whether plasma lipoproteins and lipid responsiveness to a dietary modification is influenced by CETP gene polymorphism.


Condition Intervention
Metabolic Syndrome
 Other: Dietary experiments

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: Study the Role of Polymorphism at the CETP Gene Locuse in the Determining Lipid Profile Response to Dietary Change

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Tabriz University:

Enrollment: 102
Study Start Date: October 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1 Other: Dietary experiments
Dietary Supplement: high PUFA diet followed by high SFA diet
Experimental: 2 Other: Dietary experiments
Dietary Supplement: high PUFA diet followed by high SFA diet
Experimental: 3 Other: Dietary experiments
Dietary Supplement: high PUFA diet followed by high SFA diet

  Eligibility

Ages Eligible for Study:   18 Years to 35 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Healthy Volunteers

Exclusion Criteria:

  • History of any cardiovascular diseases
  • type 1 diabetes
  • type 2 diabetes
  • use of lipid-lowering medications
  • hypertension
  • pregnancy
  • Current intake of vitamins and supplements
  • History of endocrin disorder
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00673023

Sponsors and Collaborators
Tabriz University
Investigators
Study Director: Mohammad Noori, PhD Tabriz University
  More Information

No publications provided

Responsible Party: vice-chancellor for reseach, Tabriz University, Deputy of Research
ClinicalTrials.gov Identifier: NCT00673023     History of Changes
Other Study ID Numbers: 8641
Study First Received: May 4, 2008
Last Updated: May 4, 2008
Health Authority: Iran: Ministry of Health

Additional relevant MeSH terms:
Metabolic Syndrome X
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on May 19, 2013